Article
Why Does CAR-T Cell Therapy Fail? MSK Research Points to FAS-L Proteins
Read about a new discovery that could lead to more powerful cell-based therapies for cancer.
A New Cellular Immunotherapy Approach May Offer Treatment for AML and MDS
Laboratory research shows how it may be possible to develop an immunotherapy-based approach for treating aggressive forms of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Feature
A New Type of Immunotherapy: MSK’s Christopher Klebanoff Is Fighting Cancer Cells From the Inside Out With T Cell Receptor (TCR) Therapy
Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.
In the Lab
CAR T Cells Get an Invisibility Cloak
Research is focusing on ways to help cancer-fighting immune cells stick around longer, boosting their effectiveness.
